Eric Lefkofksy is one of the leading innovators in the field of medicinal science. He is one of the founders and CEO of Tempus, a technologically based company that is creating the world’s biggest collection of clinical and molecular data and its own operating system in order to make the data accessible to anyone and useful in the years to come. He went to the University of Michigan to study college, and graduated in 1991. He continued his studies and entered the University of Michigan Law School where he received his Juris Doctor back in the year 1993.
Tempus, a company where Eric Lefkofsky serves as a chief executive officer, focuses on scientific endeavors that would help cancer patients. They managed to categorize their work habits into four main actions: sequencing, analytics, reporting and validation. Sequencing refers to the approach that uses transcriptomic and genomic sequencing inside their laboratories and also uses in-depth machine learning to help physicians around the world understand the tumor of each of their patients. Analytics then allows the physicians to comprehend and extract molecular data, usually coming with clinical data to discover new treatment selections. Finally, they would deliver a comprehensive report and then develop new technologies that allow them to screen appropriate therapies for patients. These approach has helped Tempus become one of the largest medical companies in the world that aims to help cancer patients.
One of Eric Lefkofsky’s known charitable works would be the Lefkofsky Foundation, a charitable trust whose purpose is to support the scientific, educational and charitable organizations worldwide, focusing mainly on children and has managed to reach out to at least 50 organizations ever since. His online presence is considered to be very active; as he welcomes queries especially about his projects and answers them personally. He is also one of those who influenced taking the Olympics back to Chicago, when the city placed its bid to host the 2016 edition of the games. Eric Lefkofsky keeps on sharing his knowledge to the scientific community and hopes to improve the lives of patients in the future.